Volume 19 Issue 8
Aug.  2021
Turn off MathJax
Article Contents
ZENG Li-yan, WANG Qian, MENG Xian-min, KE Jing, DONG Hua-juan, LU Hong-zhou. Process management of biological samples in phase Ⅰ clinical trials[J]. Chinese Journal of General Practice, 2021, 19(8): 1403-1407. doi: 10.16766/j.cnki.issn.1674-4152.002071
Citation: ZENG Li-yan, WANG Qian, MENG Xian-min, KE Jing, DONG Hua-juan, LU Hong-zhou. Process management of biological samples in phase Ⅰ clinical trials[J]. Chinese Journal of General Practice, 2021, 19(8): 1403-1407. doi: 10.16766/j.cnki.issn.1674-4152.002071

Process management of biological samples in phase Ⅰ clinical trials

doi: 10.16766/j.cnki.issn.1674-4152.002071
Funds:

 2017ZX09304027

  • Received Date: 2020-09-14
    Available Online: 2022-02-16
  •   Objective  The quality of biological sample management in phase Ⅰ clinical trials directly affects the authenticity and accuracy of clinical trial results. In recent years, the management of biological samples has become one of the research issues of great concern in China and abroad. This study established a process management system for biological samples in phase Ⅰ clinical trials, aiming to improve the quality and efficiency of biological samples and provide a reference for standardising biological sample management in phase Ⅰ clinical trials.  Methods  The experience from the standardisation and information requirements of biological sample management was summarised, and the procedures that affect the quality of biological samples in phase Ⅰ clinical trials, including personnel, labelling, reception, transfer, processing, equipment, materials, standard operating procedure (SOP), document management and sample information management, were described.  Results  A set of standardised process management system of biological samples has been established relying on biological sample information management system, temperature intelligent monitoring and alarm management system, professional sample management personnel, complete system and SOP to improve the quality of sample management. By the end of December 2020, it has been inspected on site by the National Medical Products Administration for 42 times and the provincial Medical Products Administration for 5 times, and exempted for inspection for 29 times, covering more than 60 drugs, all of which have passed the inspection successfully.  Conclusion  High-quality clinical biological samples are one of the core factors for the reliability, completeness and scientificity of phase Ⅰ clinical research data and results. The establishment of a standardised process of sample management system can improve the research quality of drug clinical trials, effectively prevent or reduce the occurrence of problems such as sample transportation, sample processing, in-and-out storage and daily management during the process management of biological samples, and ensure the accuracy, comparability and repeatability of drug clinical trial results.

     

  • loading
  • [1]
    张媛媛, 王亮, 程龙妹, 等. 生物样本信息化管理的应用与挑战[J]. 中国临床药理学杂志, 2018, 34(14): 1710-1713. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ201814036.htm
    [2]
    HARATI M D, WILLIAMS R R, MOVASSAGHI M, et al. An introduction to starting a biobank[J]. Methods Mol Biol, 2019, 1897: 7-16. http://www.ncbi.nlm.nih.gov/pubmed/30539430
    [3]
    BISHOP D. Rein in the four horsemen of irreproducibility[J]. Nature, 2019, 568(7753): 435. doi: 10.1038/d41586-019-01307-2
    [4]
    BAKER M, DOLGIN E. Cancer reproducibility project releases first results[J]. Nature, 2017, 541(7637): 269-270. doi: 10.1038/541269a
    [5]
    郜恒骏, 杜莉利, 张小燕, 等. 生物样本库发展的现状、机遇与挑战[J]. 协和医学杂志, 2018, 9(2): 172-176. doi: 10.3969/j.issn.1674-9081.2018.02.013
    [6]
    国家药监局, 国家卫生健康委. 2020年第57号国家药监局国家卫生健康委关于发布药物临床试验质量管理规范的公告[EB/OL]. (2020-04-23)[2020-09-10]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20200426162401243.html.
    [7]
    朱园园, 王思扬, 任健, 等. 临床试验生物样本的处理与保存规范[J]. 中国药物与临床, 2019, 19(16): 2846-2847. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201916080.htm
    [8]
    国家食品药品监督管理局. 2017年第77号总局关于发布仿制药质量和疗效一致性评价研制现场核查指导原则等4个指导原则的通告[EB/OL]. (2017-05-16)[2020-09-10]. https://www.nmpa.gov.cn/zhuanti/ypqxgg/ggzhcfg/20170518144401840.html.
    [9]
    李云霏, 马黔红, 邱雯. 生物样本管理系统在药物Ⅰ期临床试验样本管理中的应用[J]. 中国新药与临床杂志, 2019, 38(9): 526-532. https://www.cnki.com.cn/Article/CJFDTOTAL-XYYL201909004.htm
    [10]
    郭丹, 王安琪, 孙健, 等. 浅谈生物样本的质量保证与质量控制[J]. 中华临床实验室管理电子杂志, 2017, 5(1): 36-45. doi: 10.3877/cma.j.issn.2095-5820.2017.01.009
    [11]
    吴曼丽, 王柱清, 罗凯, 等. 临床生物样本库血液样本的可控性采集和质量管理[J]. 转化医学杂志, 2016, 5(6): 327-332. doi: 10.3969/j.issn.2095-3097.2016.06.003
    [12]
    周君梅, 王敏, 张勘, 等. 支撑高质量转化研究的临床研究全流程样本管理体系的建立[J]. 中国医药生物技术, 2019, 14(5): 474-476. doi: 10.3969/j.issn.1673-713X.2019.05.016
    [13]
    杨燕, 白楠, 唐铭婧, 等. Ⅰ期临床试验样本管理系统在我院的开发与应用[J]. 中国新药杂志, 2018, 27(24): 2925-2927. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXYZ201824015.htm
    [14]
    胡薏慧, 汤洁, 彭朋, 等. 关于当前我国新药临床试验质量问题的思考[J]. 广东药科大学学报, 2019, 35(2): 279-284. https://www.cnki.com.cn/Article/CJFDTOTAL-GDYX201902032.htm
    [15]
    贾雨婷, 白楠, 董瑶, 等. 基于物联网技术的Ⅰ期临床试验智能生物样本管理系统的应用与发展[J]. 中国临床药理学杂志, 2020, 36(2): 206-208. https://www.cnki.com.cn/Article/CJFDTOTAL-GLYZ202002031.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (223) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return